| Drug Name |
Ferric carboxymaltose |
| Drug ID |
BADD_D00882 |
| Description |
Ferric Carboxymaltose is an iron replacement product and chemically, an iron carbohydrate complex. FDA approved on July 25, 2013. |
| Indications and Usage |
Ferric carboxymaltose is a iron replacement product indicated for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron or those who have non-dialysis dependent chronic kidney disease. |
| Marketing Status |
Prescription |
| ATC Code |
Not Available |
| DrugBank ID |
DB08917
|
| KEGG ID |
D08920
|
| MeSH ID |
C522335
|
| PubChem ID |
86278165
|
| TTD Drug ID |
D02ICI
|
| NDC Product Code |
59353-363; 64552-4070; 0517-0620; 42973-330; 14593-923 |
| Synonyms |
ferric carboxymaltose | iron carboxymaltose | iron dextri-maltose | polynuclear iron (III)-hydroxide 4(R)-(poly-(1->4)-o-alpha-D-glucopyranosyl)-oxy-2(R),3(S),5(R), 6-tetrahydroxy-hexanoate | Ferinject | VIT-45 | VIT 45 | injectafer |
